Write in a clean editor, then format for Journal of Veterinary Pharmacology and Therapeutics in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Veterinary Pharmacology and Therapeutics is a peer-reviewed journal published by Wiley, covering Antibiotics Pharmacokinetics and Efficacy, Veterinary Pharmacology and Anesthesia, Drug Transport and Resistance Mechanisms.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Veterinary Pharmacology and Therapeutics 12 (3): 45–58.
Formats any DOI in Journal of Veterinary Pharmacology and Therapeutics style. No sign-up. |
| Publishes research in | Antibiotics Pharmacokinetics and Efficacy Veterinary Pharmacology and Anesthesia Drug Transport and Resistance Mechanisms Veterinary Equine Medical Research Antibiotic Resistance in Bacteria |
| ISSN | 0140-7783 |
| Citation impact (2-yr) | 1.18 |
| h-index | 89 |
| i10-index | 2,095 |
| Total citations | 73,836 |
| Article processing charge | $4,220 |
| Top institutions publishing here | University of California, Davis |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
5-Hydroxytryptamine, or serotonin, is a biogenic amine most noted for its role as a neurotransmitter. Manipulation of serotonin in animal models was used as a tool for studying its role in humans. Through such research serotonin has been shown to modulate gastrointestinal motility, peripheral vascular tone, cerebral vascular tone, and platelet function and has been…
The fluoroquinolones are a series of synthetic antibacterial agents that are undergoing extensive investigation for both human and veterinary use in the treatment of a variety of bacterial infections. These agents work through the inhibition of DNA gyrase, interfering with the supercoiling of bacterial chromosomal material. As a result, these agents are rapidly bactericidal primarily…
Terminal plasma half-life is the time required to divide the plasma concentration by two after reaching pseudo-equilibrium, and not the time required to eliminate half the administered dose. When the process of absorption is not a limiting factor, half-life is a hybrid parameter controlled by plasma clearance and extent of distribution. In contrast, when the…
